Id |
Subject |
Object |
Predicate |
Lexical cue |
T167 |
0-70 |
Sentence |
denotes |
Figure 5 Immune Dysregulation Caused by SARS-CoV-2 Is Mediated by IL-6 |
T168 |
71-184 |
Sentence |
denotes |
(A) Negative correlation between serum amounts of IL-6 and the absolute numbers of the mHLA-DR on CD14 monocytes. |
T169 |
185-273 |
Sentence |
denotes |
The Spearman’s (rs) co-efficient of correlation and the respective p value are provided. |
T170 |
274-382 |
Sentence |
denotes |
(B) Correlation between the absolute lymphocyte count and the absolute numbers of mHLA-DR on CD14 monocytes. |
T171 |
383-458 |
Sentence |
denotes |
The rs co-efficient of correlation and the respective p value are provided. |
T172 |
459-655 |
Sentence |
denotes |
(C) Changes of the absolute numbers of mHLA-DR on CD14 monocytes of four patients infected by SARS-CoV-2 with intermediate state of immune activation after incubation with medium and their plasma. |
T173 |
656-838 |
Sentence |
denotes |
(D) Changes of the MFI of HLA-DR on CD14 monocytes of four patients infected by SARS-CoV-2 with intermediate state of immune activation after incubation with medium and their plasma. |
T174 |
839-1100 |
Sentence |
denotes |
(E) Changes of the absolute numbers of mHLA-DR on CD14 monocytes of eight patients infected by SARS-CoV-2 with immune dysregulation after incubation with medium and their plasma; modulation by the addition of the specific IL-6 blocker Tocilizumab is also shown. |
T175 |
1101-1348 |
Sentence |
denotes |
(F) Changes of the MFI of HLA-DR on CD14 monocytes of eight patients infected by SARS-CoV-2 with immune dysregulation after incubation with medium and their plasma; modulation by the addition of the specific IL-6 blocker tocilizumab is also shown. |
T176 |
1349-1463 |
Sentence |
denotes |
(G) Changes of the absolute lymphocyte count of six patients before and after start of treatment with Tocilizumab. |
T177 |
1464-1608 |
Sentence |
denotes |
(H) Intracellular staining for IL-6 in CD14 monocytes and in CD4 lymphocytes of three patients infected by SARS-CoV-2 with immune dysregulation. |
T178 |
1609-1705 |
Sentence |
denotes |
Statistical comparisons are indicated by the arrows; ns: non-significant; ∗p < 0.05; ∗∗p < 0.01. |